Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PMN

ProMIS Neurosciences (PMN)

ProMIS Neurosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:PMN
DateTimeSourceHeadlineSymbolCompany
07/18/20193:00PMPR Newswire (US)ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019TSX:PMNProMIS Neurosciences Inc
07/18/20193:00PMPR Newswire (Canada)ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019TSX:PMNProMIS Neurosciences Inc
07/10/20197:30AMPR Newswire (US)ProMIS Neurosciences to Present Data at 2019 Alzheimer's Association International ConferenceTSX:PMNProMIS Neurosciences Inc
07/10/20197:30AMPR Newswire (Canada)ProMIS Neurosciences to Present Data at 2019 Alzheimer's Association International ConferenceTSX:PMNProMIS Neurosciences Inc
07/09/20197:30AMPR Newswire (Canada)ProMIS Neurosciences' Data for Alzheimer's Disease Clinical Candidate PMN310 Published in Scientific ReportsTSX:PMNProMIS Neurosciences Inc
07/09/20197:30AMPR Newswire (US)ProMIS Neurosciences' Data for Alzheimer's Disease Clinical Candidate PMN310 Published in Scientific ReportsTSX:PMNProMIS Neurosciences Inc
06/27/20197:30AMPR Newswire (Canada)ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed AntibodiesTSX:PMNProMIS Neurosciences Inc
06/27/20197:30AMPR Newswire (US)ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed AntibodiesTSX:PMNProMIS Neurosciences Inc
06/26/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Closing Private PlacementTSX:PMNProMIS Neurosciences Inc
06/19/20197:30AMPR Newswire (US)ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory BoardTSX:PMNProMIS Neurosciences Inc
06/19/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory BoardTSX:PMNProMIS Neurosciences Inc
06/05/20197:30AMPR Newswire (US)ProMIS Neurosciences Presents Lead Program for Alzheimer's Disease at Prestigious Keystone Symposia Scientific ConferenceTSX:PMNProMIS Neurosciences Inc
06/05/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Presents Lead Program for Alzheimer's Disease at Prestigious Keystone Symposia Scientific ConferenceTSX:PMNProMIS Neurosciences Inc
05/29/20197:30AMPR Newswire (US)ProMIS Neurosciences' Eugene Williams to Present at JLABS' Conference on Innovations in Neurodegenerative DiseasesTSX:PMNProMIS Neurosciences Inc
05/29/20197:30AMPR Newswire (Canada)ProMIS Neurosciences' Eugene Williams to Present at JLABS' Conference on Innovations in Neurodegenerative DiseasesTSX:PMNProMIS Neurosciences Inc
05/28/20197:30AMPR Newswire (US)ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of TauTSX:PMNProMIS Neurosciences Inc
05/28/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of TauTSX:PMNProMIS Neurosciences Inc
05/14/20197:30AMPR Newswire (US)ProMIS Neurosciences Announces First Quarter 2019 ResultsTSX:PMNProMIS Neurosciences Inc
05/14/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Announces First Quarter 2019 ResultsTSX:PMNProMIS Neurosciences Inc
04/23/20197:30AMPR Newswire (US)ProMIS Neurosciences to Participate in the Think Equity Investor ConferenceTSX:PMNProMIS Neurosciences Inc
04/23/20197:30AMPR Newswire (Canada)ProMIS Neurosciences to Participate in the Think Equity Investor ConferenceTSX:PMNProMIS Neurosciences Inc
03/26/20197:30AMPR Newswire (Canada)ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019TSX:PMNProMIS Neurosciences Inc
03/26/20197:30AMPR Newswire (US)ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019TSX:PMNProMIS Neurosciences Inc
03/21/20192:47PMPR Newswire (US)Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's DiseaseTSX:PMNProMIS Neurosciences Inc
03/21/20192:47PMPR Newswire (Canada)Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's DiseaseTSX:PMNProMIS Neurosciences Inc
03/19/20197:30AMPR Newswire (US)ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD™ 2019...TSX:PMNProMIS Neurosciences Inc
03/19/20197:30AMPR Newswire (Canada)ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD™ 2019...TSX:PMNProMIS Neurosciences Inc
03/15/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Announces Fiscal Year 2018 Annual ResultsTSX:PMNProMIS Neurosciences Inc
03/15/20197:30AMPR Newswire (US)ProMIS Neurosciences Announces Fiscal Year 2018 Annual ResultsTSX:PMNProMIS Neurosciences Inc
02/21/20197:30AMPR Newswire (Canada)ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of AdvisorsTSX:PMNProMIS Neurosciences Inc
 Showing the most relevant articles for your search:TSX:PMN